The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Baker Bros. Investments, L.p. since 2013.
The trader's CIK number is 1551136.
At the time of the last reporting, Baker Bros. Investments, L.p. was the 10% Owner of Genomic Health Inc. (stock ticker symbol GHDX).
Also see all insider trading activities at Genomic Health Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | GHDX | 0 | $0 | 204,300 | $16,353,406 | 0 | $0 |
2016 | GHDX | 100,000 | $2,701,600 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | BCRX | 1,136,364 | $5,000,001 | 0 | $0 | 0 | $0 |
2. Biocryst Pharmaceuticals Inc (BCRX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-11-13 | GHDX | Sale | 138,712 | 79.67 | 11,051,601 |
2018-11-12 | GHDX | Sale | 65,588 | 80.83 | 5,301,805 |
2016-08-15 | GHDX | Buy | 100,000 | 27.02 | 2,701,600 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-08-01 | BCRX | Buy | 1,136,364 | 4.40 | 5,000,001 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Bros. Investments, L.p. (10% Owner of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.